What criteria do you use to treat the supraclavicular region in women with T1-2 disease breast cancer and 1-3 positive lymph nodes?
Answer from: Radiation Oncologist at Academic Institution
When seeing a patient in this situation, I ask myself, "Does this patient seem more like an ACOSOG Z11 patient or an MA.20 patient?" The MA.20 trial, presented at ASCO in 2011, suggested that regional nodal radiation improved distant disease-free survival compared to breast only radiation. While not...
Comments
Radiation Oncologist at SSM Cancer Center/St Louis CyberKnife Thanks for your response @Benjamin D. Smith. As a ...
Thanks for your response @Benjamin D. Smith. As a ...